PharmaEssentia Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 1,264.84 million compared to TWD 977.73 million a year ago. Net loss was TWD 202.76 million compared to TWD 274.7 million a year ago. Basic loss per share from continuing operations was TWD 0.62 compared to TWD 0.98 a year ago.
For the six months, sales was TWD 2,152.48 million compared to TWD 1,229.47 million a year ago. Net loss was TWD 938.3 million compared to TWD 815.56 million a year ago. Basic loss per share from continuing operations was TWD 2.98 compared to TWD 2.93 a year ago.